Two subjects at week 14 and three subjects with bilateral brain involvement had at the last visit a greater than 50% seizure reduction, reported an improved quality of life, and remained on cannabidiol 63-80 weeks after starting the drug. Three subjects reported mild side effects considered related to cannabidiol.
Link: Cannabidiol Treatment for Refractory Seizures in Sturge-Weber Syndrome
Year: 2017
DOI: http://dx.doi.org/10.1016/j.pediatrneurol.2017.02.009
Probability toward demonstrable efficacy of cannabis for treatment of Sturge-Weber Syndrome according to the results found in this study.
CBD